The Dangers of GranuFlo Dialysis Treatment
What's the Problem?
The addition of extra bicarbonate in GranuFlo has the potential to lead to serious side effects such as:
Studies have found that elevated biocarbonate levels in the blood can increase the risk of heart attack six fold.
In 2010 alone, 941 patients suffered heart attacks while receiving dialysis treatment.
The main problem with GranuFlo seems to be its potential to cause metabolic alkalosis, a condition that has been linked to serious side effects including:
Low Blood Pressure
Sudden Heart Attack
Hemodialysis Cardiopulmonary Arrest
In late 2011, executives from Fresenius Medical Care sent an internal memo describing the irsk of elevated bicarbonate levels. The memo reportedly discussed 'troubling findings,' and alerted staff that the issue needed to be addressed urgently. However, FMC failed to pass this info to the estimated 125,000 patients being treated with GranuFlo.
Instead, federal health regulators were not warned of the dangers until early 2012, when the memo was leaked to the FDA. Only on March 29, 2012, over four months later, did FMC issue a warning about GranuFlo.